September 15, 2024

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer

New England Journal of Medicine, Ahead of Print.

September 15, 2024

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

New England Journal of Medicine, Ahead of Print.

September 15, 2024

AstraZeneca’s Imfinzi increases survival rates in bladder cancer in pivotal study – STAT

September 12, 2024

Improving the Bladder Cancer Survivorship Experience for Women – Consult QD

September 11, 2024

Improving bladder cancer treatment – Queen’s University